# Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)

> **NCT03146338** · NA · UNKNOWN · sponsor: **Weprom** · enrollment: 106 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Metastatic Head and Neck Cancer

## Interventions

- **OTHER:** Magnesium-rich mineral water (Rozana)

## Key facts

- **NCT ID:** NCT03146338
- **Lead sponsor:** Weprom
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-04
- **Primary completion:** 2021-05-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146338, "Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03146338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*